Remember meForgot password?
    Log in with Twitter
Press Release

Xarelto Lawsuit Update: Son of Georgia Man Files Wrongful Death Lawsuit in MDL reports today on one of the more recent lawsuits filed in the Xarelto multidistrict litigation.  This particular lawsuit was filed in the United States District Court for the Eastern District of Louisiana on March 20, 2015 by the son of a Georgia man who recently passed away from complications due to an internal bleeding incident.  The case is filed under case number 2:15-cv-00886 and the full complaint can be downloaded and read here.

New Lawsuit Filed Against Xarelto

The plaintiff, the son, is a resident of Tennessee.  He is alleging that his father’s death was caused by an uncontrollable internal bleeding incident directly linked to his father’s Xarelto usage.  The complaint outlines that the plaintiff’s father was initially prescribed Xarelto in November 2012 to treat a heart condition he suffered from known as atrial fibrillation.  The plaintiff’s father continued to take Xarelto until he died due to an internal bleed in March of 2013.  The complaint details that the deceased would not have taken Xarelto if him and his son were fully aware of the real risks that the drug presented.  If they were fully aware of the risks, they would have opted for a much safer alternative.

The Real Dangers of Xarelto

Xarelto is a part of a new class of blood thinners called Xa inhibitors.  Xa inhibitors work differently from traditional blood thinners because it blocks the chemical in the blood responsible for making the blood clot, thrombin.  By blocking thrombin, Xarelto completely takes away the blood’s ability to clot.  This is extremely dangerous because there is currently no antidote for Xarelto’s anticoagulant effects.  The lack of antidote means that if a patient taking Xarelto and experiences an internal bleeding injury, there is no way to stop the bleeding.  This is a very different situation than patients taking the traditional blood thinner Warfarin are in.  If a patient taking Warfarin experiences an internal bleeding injury, a doctor can simply administer vitamin K and the patient’s blood will clot.

Many of the lawsuits filed in the multidistrict litigation allege that the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, had prior knowledge of the true dangers of the drug yet released Xarelto onto the U.S. market anyway.  They also allege that releasing Xarelto without an antidote was negligent and irresponsible.

“If you or a loved one have been harmed due to your Xarelto usage, do not hesitate to contact us for a free consultation.” Xarelto attorney Marc Goldich said, “We expect to see even more cases filed as the litigation progresses.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.



Marc Goldich
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

Latest News
Top News